Clinical Trial Update: Safety, Efficacy, and Survival Outcomes of Neoadjuvant/Induction Immunotherapy in Surgical and Radiotherapeutic Management of Non-Small Cell Lung Cancer

View source ↗

Summary

A clinical trial updating on safety, efficacy, and survival outcomes for neoadjuvant/induction immunotherapy in surgical and radiotherapeutic management of non-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Lung Cancer (NSCLC), Neoadjuvant Immunotherapy | Status: RECRUITING